Unknown

Dataset Information

0

Illicium sesquiterpenes: divergent synthetic strategy and neurotrophic activity studies.


ABSTRACT: Majucin-type sesquiterpenes from Illicium sp., such as jiadifenolide (2), jiadifenin (3), and (1R,10S)-2-oxo-3,4-dehydroxyneomajucin (4, ODNM), possess a complex caged chemical architecture and remarkable neurotrophic activities. As such, they represent attractive small-molecule leads against various neurodegenerative diseases. We present an efficient, enantioselective, and unified synthesis of 2, 3, and 4 and designed analogues that diverge from tetracyclic key intermediate 7. The synthesis of 7 is highlighted by the use of an enantioselective Robinson annulation reaction (construction of the AB rings), a Pd-mediated carbomethoxylation reaction (construction of the C ring), and a one-pot oxidative reaction cascade (construction of the D ring). Evaluation of the neurotrophic activity of these compounds led to the identification of several highly potent small molecules that significantly enhanced the activity of nerve growth factor (NGF) in PC-12 cells. Moreover, efforts to define the common pharmacophoric motif suggest that substitution at the C-10 center significantly affects bioactivity, while the hemiketal moiety of 2 and 3 and the C-1 substitution might not be critical to the neurotrophic activity.

SUBMITTER: Trzoss L 

PROVIDER: S-EPMC3875175 | biostudies-literature | 2013 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Illicium sesquiterpenes: divergent synthetic strategy and neurotrophic activity studies.

Trzoss Lynnie L   Xu Jing J   Lacoske Michelle H MH   Mobley William C WC   Theodorakis Emmanuel A EA  

Chemistry (Weinheim an der Bergstrasse, Germany) 20130322 20


Majucin-type sesquiterpenes from Illicium sp., such as jiadifenolide (2), jiadifenin (3), and (1R,10S)-2-oxo-3,4-dehydroxyneomajucin (4, ODNM), possess a complex caged chemical architecture and remarkable neurotrophic activities. As such, they represent attractive small-molecule leads against various neurodegenerative diseases. We present an efficient, enantioselective, and unified synthesis of 2, 3, and 4 and designed analogues that diverge from tetracyclic key intermediate 7. The synthesis of  ...[more]

Similar Datasets

| S-EPMC6563921 | biostudies-literature
| S-EPMC8838251 | biostudies-literature
| S-EPMC5261859 | biostudies-literature
| S-EPMC5729088 | biostudies-literature
| S-EPMC3701413 | biostudies-literature
| S-EPMC10126200 | biostudies-literature
| S-EPMC6335630 | biostudies-literature
2015-01-20 | E-GEOD-54979 | biostudies-arrayexpress
| S-EPMC7212320 | biostudies-literature
| PRJNA297698 | ENA